GSK Faces Whistleblower Suit From Lab That Found Zantac Risk

Share!

Insurance Journal - May 21, 2024

GSK Plc is facing a whistleblower lawsuit that could potentially cost it billions of dollars from the laboratory that revealed the presence of a probable carcinogen in Zantac, the heartburn medication that the UK drugmaker invented and turned into a …...

Read Full Article

Recommended Articles

Texas Summer Camp Faces Scrutiny Over Failure to Report Deaths

Posted: Apr 16, 2026

The medical officer for the Texas summer camp where 27 girls were killed in a flood last year testif...

Trucordia Buys Connecticut’s Paradiso Insurance Services

Posted: Apr 16, 2026

Utah-based insurance broker Trucordia reports it has acquired the Paradiso Financial and Insurance S...

Inszone Acquires Kansas’ Insurance Resources Group

Posted: Apr 16, 2026

Inszone Insurance Services announced the acquisition of Insurance Resources Group, Inc. Located in O...